bremelanotide acetate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
8 FDA-registered drug labelers
Cosette Pharmaceuticals, Inc.
DARMERICA, LLC
El-Peptido (Shanghai) Biopharmaceutical Co., Ltd
Evereen Shanghai Biotechnology Ltd.
Hangzhou Yiqi Biotechnology Co., Ltd
Palatin Technologies
Qingdao Biopeptek Co., Ltd.
Shenzhen Alvantis Pharma Co., Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Vyleesi
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS1607799-13-2
PubChem CID91971505
DTXSIDDTXSID801027730
FormulaC52H72N14O12
Mol. Weight1085.2 g/mol
SMILESCCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C.CC(=O)O
Data Sources
919715052026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/bremelanotide acetate/cids/JSON
Archive: data/sources/pubchem_name/bremelanotide acetate.json
CAS 1607799-13-22026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json